loadpatents
name:-0.10161209106445
name:-0.10759997367859
name:-0.027898073196411
Evans; Ronald M. Patent Filings

Evans; Ronald M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Evans; Ronald M..The latest application filed is for "compositions and methods for treating type 1 and type 2 diabetes and related disorders".

Company Profile
29.109.99
  • Evans; Ronald M. - La Jolla CA
  • Evans; Ronald M. - LaJolla CA
  • Evans; Ronald M - La Jolla CA
  • Evans; Ronald M. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Analogs of fexaramine and methods of making and using
Grant 11,440,889 - Evans , et al. September 13, 2
2022-09-13
PPAR agonists
Grant 11,420,934 - Evans , et al. August 23, 2
2022-08-23
Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment
Grant 11,376,264 - Evans , et al. July 5, 2
2022-07-05
PPAR agonists and methods of use thereof
Grant 11,130,779 - Evans , et al. September 28, 2
2021-09-28
Compositions And Methods For Treating Type 1 And Type 2 Diabetes And Related Disorders
App 20210283187 - EVANS; RONALD M. ;   et al.
2021-09-16
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20210253549 - Downes; Michael ;   et al.
2021-08-19
Analogs Of Fexaramine And Methods Of Making And Using
App 20210147365 - Evans; Ronald M. ;   et al.
2021-05-20
Compositions and methods for treating type 1 and type 2 diabetes and related disorders
Grant 10,912,800 - Evans , et al. February 9, 2
2021-02-09
Fibroblast Growth Factor 1 (fgf1) Mutant Proteins That Selectively Activate Fgfr1b To Reduce Blood Glucose
App 20210032303 - Evans; Ronald M. ;   et al.
2021-02-04
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,906,885 - Downes , et al. February 2, 2
2021-02-02
Analogs of fexaramine and methods of making and using
Grant 10,815,203 - Evans , et al. October 27, 2
2020-10-27
Ppar Agonists And Methods Of Use Thereof
App 20200216490 - Evans; Ronald M. ;   et al.
2020-07-09
Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs
Grant 10,695,404 - Evans , et al.
2020-06-30
Ppar Agonists
App 20200190019 - Evans; Ronald M. ;   et al.
2020-06-18
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20200157074 - Downes; Michael ;   et al.
2020-05-21
Use Of Bromodomain-containing Protein 9 Antagonists In Combination With Vitamin D Receptor Agonists In Diabetes Treatment
App 20200129532 - Evans; Ronald M. ;   et al.
2020-04-30
Analogs Of Fexaramine And Methods Of Making And Using
App 20200123113 - Evans; Ronald M. ;   et al.
2020-04-23
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20200040051 - Evans; Ronald M. ;   et al.
2020-02-06
PPAR agonists
Grant 10,550,071 - Evans , et al. Fe
2020-02-04
PPAR agonists and methods of use thereof
Grant 10,550,149 - Evans , et al. Fe
2020-02-04
Methods For Treating Metabolic Disorders Using Fgf
App 20190358296 - Jonker; Johan W. ;   et al.
2019-11-28
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,479,775 - Downes , et al. Nov
2019-11-19
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20190337920 - Downes; Michael ;   et al.
2019-11-07
Analogs of fexaramine and methods of making and using
Grant 10,450,277 - Evans , et al. Oc
2019-10-22
Use Of Fibroblast Growth Factor 1 (fgf1)-vagus Nerve Targeting Chimeric Proteins To Treat Hyperglycemia
App 20190276510 - Evans; Ronald M. ;   et al.
2019-09-12
Methods for treating metabolic disorders using FGF
Grant 10,398,759 - Jonker , et al. Sep
2019-09-03
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
Grant 10,399,958 - Downes , et al. Sep
2019-09-03
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20190192630 - Suh; Jae Myoung ;   et al.
2019-06-27
Analogs of fexaramine and methods of making and using
Grant 10,301,268 - Evans , et al.
2019-05-28
Fibroblast Growth Factor (fgf) 1 Proteins With Glucose Lowering Ability And Reduced Mitogenicity
App 20190151416 - Evans; Ronald M. ;   et al.
2019-05-23
Methods for treating metabolic disorders using FGF
Grant 10,293,027 - Jonker , et al.
2019-05-21
Vitamin D receptor/SMAD genomic circuit gates fibrotic response
Grant 10,238,667 - Ding , et al.
2019-03-26
Analogs Of Fexaramine And Methods Of Making And Using
App 20190084939 - Evans; Ronald M. ;   et al.
2019-03-21
Ppar Agonists, Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20190084958 - Downes; Michael ;   et al.
2019-03-21
Methods for treating metabolic disorders using FGF
Grant 10,159,711 - Jonker , et al. Dec
2018-12-25
Increasing Storage Of Vitamin A, Vitamin D And/or Lipids
App 20180325914 - Evans; Ronald M. ;   et al.
2018-11-15
Fgf2 Truncations And Mutants And Uses Thereof
App 20180319857 - Evans; Ronald M. ;   et al.
2018-11-08
Ppar Agonists And Methods Of Use Thereof
App 20180305403 - Evans; Ronald M. ;   et al.
2018-10-25
FXR agonists and methods for making and using
Grant 10,077,268 - Evans , et al. September 18, 2
2018-09-18
Treatment Of Steroid-induced Hyperglycemia With Fibroblast Growth Factor (fgf) 1 Analogs
App 20180228869 - Evans; Ronald M. ;   et al.
2018-08-16
PPAR agonists and methods of use thereof
Grant 10,035,819 - Evans , et al. July 31, 2
2018-07-31
ESTROGEN RELATED RECEPTOR GAMMA (ERRgamma) ENHANCES AND MAINTAINS BROWN FAT THERMOGENIC CAPACITY
App 20180207114 - Evans; Ronald M. ;   et al.
2018-07-26
Vitamin D Receptor Agonists To Treat Diseases Involving Cxcl12 Activity
App 20180200379 - Sherman; Mara ;   et al.
2018-07-19
Methods For Treating Metabolic Disorders Using Fgf
App 20180200334 - Jonker; Johan W. ;   et al.
2018-07-19
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20180193418 - Suh; Jae Myoung ;   et al.
2018-07-12
Ppar Agonists
App 20180170857 - Evans; Ronald M. ;   et al.
2018-06-21
PPAR agonists
Grant 9,938,234 - Evans , et al. April 10, 2
2018-04-10
Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use
Grant 9,925,243 - Suh , et al. March 27, 2
2018-03-27
Mutated fibroblast growth factor (FGF) 1 and methods of use
Grant 9,925,241 - Suh , et al. March 27, 2
2018-03-27
Vitamin D Receptor/smad Genomic Circuit Gates Fibrotic Response
App 20180071318 - Ding; Ning ;   et al.
2018-03-15
Fibroblast Growth Factor (fgf) 1 Mutants And Methods Of Use To Reduce Blood Glucose
App 20180057554 - Evans; Ronald M. ;   et al.
2018-03-01
Methods Of Treating Lipodystrophy Using Fgf-1 Compounds
App 20180050087 - McDonnell; Neil ;   et al.
2018-02-22
Vitamin D receptor agonists to treat diseases involving CXCL12 activity
Grant 9,895,381 - Sherman , et al. February 20, 2
2018-02-20
Methods For Treating Metabolic Disorders Using Fgf
App 20180036377 - Jonker; Johan W. ;   et al.
2018-02-08
Vitamin D receptor/SMAD genomic circuit gates fibrotic response
Grant 9,872,866 - Ding , et al. January 23, 2
2018-01-23
Err Alpha And Err Gamma Are Essential Coordinators Of Cardiac Metabolism And Function
App 20180015057 - Evans; Ronald M. ;   et al.
2018-01-18
Intestinal Fxr Agonism Enhances Glp-1 Signaling To Restore Pancreatic Beta Cell Functions
App 20180000768 - Fang; Sungsoon ;   et al.
2018-01-04
Methods Of Using Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods To Reduce Blood Glucose
App 20170355740 - Evans; Ronald M. ;   et al.
2017-12-14
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20170355739 - Evans; Ronald M. ;   et al.
2017-12-14
Methods for treating metabolic disorders using FGF
Grant 9,808,508 - Jonker , et al. November 7, 2
2017-11-07
Fgf2 Truncations And Mutants And Uses Thereof
App 20170291931 - Evans; Ronald M. ;   et al.
2017-10-12
Ppar Agonists And Methods Of Use Thereof
App 20170226154 - Evans; Ronald M. ;   et al.
2017-08-10
Modulation Of Estrogen Receptor-related Receptor Gamma (err Gamma) And Uses Therefor
App 20170189485 - Narkar; Vihang A. ;   et al.
2017-07-06
Compositions And Methods For Treating Type 1 And Type 2 Diabetes And Related Disorders
App 20170087189 - EVANS; RONALD M. ;   et al.
2017-03-30
Analogs Of Fexaramine And Methods Of Making And Using
App 20170066724 - Evans; Ronald M. ;   et al.
2017-03-09
Methods For Treating Metabolic Disorders Using Fgf
App 20170056475 - Jonker; Johan W. ;   et al.
2017-03-02
Compositions and methods for treating type 1 and type 2 diabetes and related disorders
Grant 9,546,379 - Evans , et al. January 17, 2
2017-01-17
Fxr Agonists And Methods For Making And Using
App 20160376279 - Evans; Ronald M. ;   et al.
2016-12-29
Methods For Treating Metabolic Disorders Using Fgf
App 20160354440 - Jonker; Johan W. ;   et al.
2016-12-08
Increasing Storage Of Vitamin A, Vitamin D And/or Lipids
App 20160331760 - Evans; Ronald M. ;   et al.
2016-11-17
Methods for treating metabolic disorders using FGF
Grant 9,446,097 - Jonker , et al. September 20, 2
2016-09-20
Epigenomic induced pluripotent stem cell signatures
Grant 9,428,811 - Evans , et al. August 30, 2
2016-08-30
Chimeric Fibroblast Growth Factor (fgf) 2/fgf1 Peptides And Methods Of Use
App 20160237133 - Suh; Jae Myoung ;   et al.
2016-08-18
Chimeric Fibroblast Growth Factor (fgf) 2/fgf1 Peptides And Methods Of Use
App 20160206695 - Suh; Jae Myoung ;   et al.
2016-07-21
Vitamin D Receptor/smad Genomic Circuit Gates Fibrotic Response
App 20160106762 - Ding; Ning ;   et al.
2016-04-21
Methods Of Treating Muscular Dystrophy
App 20160101086 - Downes; Michael ;   et al.
2016-04-14
Vitamin D Receptor Agonists To Treat Diseases Involving Cxcl12 Activity
App 20160089385 - Sherman; Mara ;   et al.
2016-03-31
Ppar Agonists
App 20160023991 - Evans; Ronald M. ;   et al.
2016-01-28
Compositions And Methods For Treating Type 1 And Type 2 Diabetes And Related Disorders
App 20150368667 - EVANS; RONALD M. ;   et al.
2015-12-24
Methods For Treating Metabolic Disorders Using Fgf
App 20150343022 - Jonker; Johan W. ;   et al.
2015-12-03
Methods for enhancing muscle performance and tone
Grant 9,192,601 - Evans , et al. November 24, 2
2015-11-24
Methods Of Using Fexaramine And Agents That Increase Sympathetic Nervous System Activity To Promote Browning Of White Adipose Tissue
App 20150258052 - Evans; Ronald M. ;   et al.
2015-09-17
Methods for treating metabolic disorders using FGF
Grant 9,072,708 - Jonker , et al. July 7, 2
2015-07-07
Modulation Of Estrogen Receptor-related Receptor Gamma (err Gamma) And Uses Therefor
App 20150119315 - Narkar; Vihang A. ;   et al.
2015-04-30
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20150111821 - Suh; Jae Myoung ;   et al.
2015-04-23
Fibroblast growth factor 1 protein fragments and methods of use
Grant 8,999,929 - Mohammadi , et al. April 7, 2
2015-04-07
Methods For Treating Metabolic Disorders Using Fgf
App 20150065419 - JONKER; JOHAN W. ;   et al.
2015-03-05
Modulation of estrogen receptor-related receptor gamma (ERR.gamma.) and uses therefor
Grant 8,962,546 - Narkar , et al. February 24, 2
2015-02-24
Methods for treating metabolic disorders using FGF
Grant 8,906,854 - Jonker , et al. December 9, 2
2014-12-09
Methods For Treating Metabolic Disorders Using Fgf
App 20140171361 - Jonker; Johan W. ;   et al.
2014-06-19
Fibroblast Growth Factor 1 Protein Fragments And Methods Of Use
App 20140155316 - Mohammadi; Moosa ;   et al.
2014-06-05
Methods For Enhancing Exercise Performance
App 20140005238 - Evans; Ronald M. ;   et al.
2014-01-02
Epigenomic Induced Pluripotent Stem Cell Signatures
App 20130295569 - Evans; Ronald M. ;   et al.
2013-11-07
Methods For Treating Metabolic Disorders Using Fgf
App 20130116171 - Jonker; Johan W. ;   et al.
2013-05-09
Modulation Of Estrogen Receptor-related Receptor Gamma (err Gamma) And Uses Therefor
App 20120302491 - Narkar; Vihang A. ;   et al.
2012-11-29
Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis
Grant 8,318,708 - Evans , et al. November 27, 2
2012-11-27
Adipose-derived Induced Pluripotent Stem Cells
App 20120263689 - Sugii; Shigeki ;   et al.
2012-10-18
Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
Grant 8,212,006 - Downes , et al. July 3, 2
2012-07-03
Methods of Identifying Functional Characteristics of Promoters, Transcription Modifying Proteins and Transcription Modulating Agents
App 20110263454 - Jonker; Johan W. ;   et al.
2011-10-27
Steroid-activated nuclear receptors and uses therefor
Grant 7,972,782 - Evans , et al. July 5, 2
2011-07-05
Methods For Enhancing Muscle Performance And Tone
App 20110112047 - Evans; Ronald M. ;   et al.
2011-05-12
Structure Of The Farnesoid X Receptor Ligand Binding Domain And Methods Of Use Therefor
App 20110018866 - Downes; Michael R. ;   et al.
2011-01-27
Use Of Vitamin D Receptor Agonists And Precursors To Treat Fibrosis
App 20110014126 - Evans; Ronald M. ;   et al.
2011-01-20
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
Grant 7,671,085 - Downes , et al. March 2, 2
2010-03-02
Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
Grant 7,647,217 - Downes , et al. January 12, 2
2010-01-12
Use Of Vitamin D Receptor Agonists And Precursors To Treat Fibrosis
App 20090209500 - EVANS; RONALD M. ;   et al.
2009-08-20
Retinoid receptor compositions and methods
Grant 7,501,487 - Mangelsdorf , et al. March 10, 2
2009-03-10
Method for modulating process mediated by farnesoid activated receptors
Grant 7,439,027 - Evans , et al. October 21, 2
2008-10-21
Modulation of metabolism of steroids and xenobiotics
Grant 7,413,853 - Evans , et al. August 19, 2
2008-08-19
Methods For Enhancing Exercise Performance
App 20080187928 - Evans; Ronald M. ;   et al.
2008-08-07
SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors
Grant 7,314,747 - Evans , et al. January 1, 2
2008-01-01
Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
Grant 7,270,955 - Evans , et al. September 18, 2
2007-09-18
Hormone receptor compositions and methods
Grant 7,214,511 - Evans , et al. May 8, 2
2007-05-08
Steroid-activated nuclear receptors and uses therefor
Grant 7,214,482 - Evans , et al. May 8, 2
2007-05-08
Response element compositions and assays employing same
Grant 7,189,510 - Sucov , et al. March 13, 2
2007-03-13
Novel steroid-activated nuclear receptors and uses therefor
App 20070026445 - Evans; Ronald M. ;   et al.
2007-02-01
Method for modulating process mediated by farnesoid activated receptors
App 20060292633 - Evans; Ronald M. ;   et al.
2006-12-28
Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
Grant 7,119,077 - Evans , et al. October 10, 2
2006-10-10
Non-steroidal farnesoid x receptor modulators
App 20060223879 - Downes; Michael R. ;   et al.
2006-10-05
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
App 20060211768 - Evans; Ronald M. ;   et al.
2006-09-21
Structure of the farnesoid x receptor ligand binding domain and methods of use therefor
App 20060194949 - Downes; Michael R. ;   et al.
2006-08-31
Novel members of the steroid/thyroid superfamily and uses therefor
App 20060154335 - Evans; Ronald M. ;   et al.
2006-07-13
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 7,056,954 - Evans , et al. June 6, 2
2006-06-06
Methods for modulating expression of exogenous genes in mammalian systems
Grant 7,045,315 - Evans , et al. May 16, 2
2006-05-16
Method for modulating processes mediated by farnesoid activated receptors
Grant 7,041,498 - Evans , et al. May 9, 2
2006-05-09
Multimeric forms of members of the steroid/thyroid superfamily of receptors
Grant 7,038,022 - Evans , et al. May 2, 2
2006-05-02
Orphan receptor TLX and uses therefor
App 20060040321 - Shi; Yanghong ;   et al.
2006-02-23
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 6,992,108 - Evans , et al. January 31, 2
2006-01-31
Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
App 20060014711 - Evans; Ronald M. ;   et al.
2006-01-19
Transgenic mice expressing a human SXR receptor polypeptide
Grant 6,984,773 - Evans , et al. January 10, 2
2006-01-10
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
App 20050143449 - Downes, Michael R. ;   et al.
2005-06-30
Xenobiotic compound modulated expression systems and uses therefor
Grant 6,911,537 - Evans June 28, 2
2005-06-28
Modulation of metabolism of steroids and xenobiotics
App 20040254135 - Evans, Ronald M. ;   et al.
2004-12-16
Inducible expression of transfected genes
App 20040235169 - Evans, Ronald M. ;   et al.
2004-11-25
Steroid-activated nuclear receptors and uses therefor
Grant 6,809,178 - Evans , et al. October 26, 2
2004-10-26
Hormone receptor compositions and methods
Grant 6,806,359 - Evans , et al. October 19, 2
2004-10-19
Hormone receptor compositions and methods
Grant 6,794,160 - Evans , et al. September 21, 2
2004-09-21
Treatment of disease states which result from neoplastic cell proliferation using PPAR-gamma activators and compositions useful therefor
App 20040162354 - Evans, Ronald M. ;   et al.
2004-08-19
Steroid-activated nuclear receptors and uses therefor
Grant 6,756,491 - Evans , et al. June 29, 2
2004-06-29
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
Grant 6,723,531 - Evans , et al. April 20, 2
2004-04-20
Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
Grant 6,706,762 - Evans , et al. March 16, 2
2004-03-16
Method for the identification and use of substances that modulate POD function and/or structure
App 20040009892 - Doucas, Vassilis ;   et al.
2004-01-15
Inducible HSV-TK in transformed cell populations
Grant 6,677,311 - Evans , et al. January 13, 2
2004-01-13
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
App 20040006144 - Evans, Ronald M. ;   et al.
2004-01-08
Histone deacetylase, and uses therefor
Grant 6,673,587 - Evans , et al. January 6, 2
2004-01-06
Novel steroid-activated nuclear receptors and uses therefor
App 20030223993 - Evans, Ronald M. ;   et al.
2003-12-04
Treatment of disease states which result from neoplastic cell proliferation using PPAR-.gamma. activators and compositions useful therefor
Grant 6,646,008 - Evans , et al. November 11, 2
2003-11-11
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
Grant 6,605,627 - Evans , et al. August 12, 2
2003-08-12
Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
App 20030138836 - Evans, Ronald M. ;   et al.
2003-07-24
Xenobiotic compound modulated expression systems and uses therefor
App 20030104519 - Evans, Ronald M.
2003-06-05
Means For The Modulation Of Processes Mediated By Retinoid Receptors And Compounds Useful Therefor
App 20030105166 - EVANS, RONALD M. ;   et al.
2003-06-05
Response element compositions and assays employing same
App 20030099926 - Sucov, Henry M. ;   et al.
2003-05-29
Allosteric control of nuclear hormone receptors
App 20030083469 - Evans, Ronald M. ;   et al.
2003-05-01
Novel Steroid-activated Nuclear Receptors And Uses Therefor
App 20030064430 - EVANS, RONALD M. ;   et al.
2003-04-03
Methods employing XOR-6, a vitamin D-like receptor from xenopus
App 20030044914 - Evans, Ronald M. ;   et al.
2003-03-06
Novel Steroid-activated Nuclear Receptors And Uses Therefor
App 20030044888 - EVANS, RONALD M. ;   et al.
2003-03-06
Method for modulating processes mediated by farnesoid activated receptors
App 20030022290 - Evans, Ronald M. ;   et al.
2003-01-30
Methods for modulating expression of exogenous genes in mammalian systems
App 20020187972 - Evans, Ronald M. ;   et al.
2002-12-12
Method For Modulating Expression Of Exogenous Genes In Mammalian Systems, And Products Related Thereto
App 20020177564 - EVANS, RONALD M. ;   et al.
2002-11-28
Heterodimer complex of RXR and NURR1 or NGFI-B
Grant 6,458,926 - Evans , et al. October 1, 2
2002-10-01
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
App 20020137665 - Evans, Ronald M. ;   et al.
2002-09-26
Use Of Rar Antagonists As Modulators Of Hormone Mediated Processes
App 20020137794 - EVANS, RONALD M. ;   et al.
2002-09-26
Drosophila Derived Receptors Of The Steroid Receptor Superfamily
App 20020102618 - EVANS, RONALD M. ;   et al.
2002-08-01
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
App 20020103119 - Evans, Ronald M. ;   et al.
2002-08-01
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
Grant 6,413,994 - Evans , et al. July 2, 2
2002-07-02
Method, polypeptides, nucleotide sequence of XOR-6, a vitamin D-like receptor from xenopus
Grant 6,391,847 - Evans , et al. May 21, 2
2002-05-21
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
Grant 6,387,673 - Evans , et al. May 14, 2
2002-05-14
Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
Grant 6,281,330 - Evans , et al. August 28, 2
2001-08-28
Methods of modulating the expression of genes using ultraspiracle receptor
Grant 6,265,173 - Evans , et al. July 24, 2
2001-07-24
Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
Grant 6,214,850 - Evans , et al. April 10, 2
2001-04-10
Method for modulating processes mediated by farnesoid activated receptors
Grant 6,184,353 - Evans , et al. February 6, 2
2001-02-06
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
Grant 6,096,787 - Evans , et al. August 1, 2
2000-08-01
Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
Grant 6,022,897 - Evans , et al. February 8, 2
2000-02-08
Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
Grant 6,005,086 - Evans , et al. December 21, 1
1999-12-21
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
Grant 5,990,163 - Evans , et al. November 23, 1
1999-11-23
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 5,968,989 - Evans , et al. October 19, 1
1999-10-19
Modulations of peroxisome proliferator activated receptor-.gamma., and methods for the use thereof
Grant 5,939,442 - Evans , et al. August 17, 1
1999-08-17
Methods for the detection of ligands for retinoid X receptors
Grant 5,906,920 - Evans , et al. May 25, 1
1999-05-25
Nucleic acids encoding peroxisome proliferator-activated receptor
Grant 5,861,274 - Evans , et al. January 19, 1
1999-01-19
Retinoid-inducible response elements
Grant 5,747,661 - Evans , et al. May 5, 1
1998-05-05
DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells
Grant 5,723,329 - Mangelsdorf , et al. March 3, 1
1998-03-03
Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements
Grant 5,702,914 - Evans , et al. December 30, 1
1997-12-30
Orphan steroid hormone receptors
Grant 5,696,233 - Evans , et al. December 9, 1
1997-12-09
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
Grant 5,668,175 - Evans , et al. September 16, 1
1997-09-16
Functional antagonism between proto-oncoprotein c-Jun and hormone receptors
Grant 5,639,592 - Evans , et al. June 17, 1
1997-06-17
Dominant negative chimeras of the steroid/thyroid superfamily of receptors
Grant 5,602,009 - Evans , et al. February 11, 1
1997-02-11
Chimeric steroid hormone superfamily receptor proteins
Grant 5,599,904 - Evans , et al. February 4, 1
1997-02-04
Hormone response element compositions and assay
Grant 5,597,693 - Evans , et al. January 28, 1
1997-01-28
Receptor transcription-repression activity compositions and methods
Grant 5,578,483 - Evans , et al. November 26, 1
1996-11-26
Retinoic acid receptor .alpha., vectors and cells comprising the same DNA encoding
Grant 5,571,692 - Evans , et al. November 5, 1
1996-11-05
Receptors
Grant 5,571,696 - Evans , et al. November 5, 1
1996-11-05
Hormone receptor compositions and methods
Grant 5,312,732 - Evans , et al. May 17, 1
1994-05-17
Receptors: their identification, characterization, preparation and use
Grant 5,310,662 - Evans , et al. May 10, 1
1994-05-10
Bioassay for identifying ligands for steroid hormone receptors
Grant 5,298,429 - Evans , et al. March 29, 1
1994-03-29
Retinoic acid receptor composition
Grant 5,274,077 - Evans , et al. December 28, 1
1993-12-28
Receptors: their identification, characterization, preparation and use
Grant 5,262,300 - Evans , et al. * November 16, 1
1993-11-16
Retinoic acid receptor composition
Grant 5,171,671 - Evans , et al. December 15, 1
1992-12-15
Beta retinoic acid response elements compositions and assays
Grant 5,091,518 - Sucov , et al. February 25, 1
1992-02-25
Hormone receptor-related bioassays
Grant 5,071,773 - Evans , et al. December 10, 1
1991-12-10
Retinoic acid receptor method
Grant 4,981,784 - Evans , et al. January 1, 1
1991-01-01
Method of obtaining gene product through the generation of transgenic animals
Grant 4,870,009 - Evans , et al. September 26, 1
1989-09-26
Human inhibin
Grant 4,737,578 - Evans , et al. April 12, 1
1988-04-12
DNA encoding human CGRP
Grant 4,736,023 - Evans , et al. April 5, 1
1988-04-05
Human CGRP
Grant 4,549,986 - Evans , et al. October 29, 1
1985-10-29
Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
Grant 4,530,838 - Evans , et al. July 23, 1
1985-07-23
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed